Brain Implant Manages Parkinson’s Movement and Sleep Issues
Researchers are developing an AI-powered brain implant that adapts in real time to control Parkinson’s symptoms, providing personalized relief for both movement challenges and insomnia.
Tag: Implants
All
Latest
All
Latest
Upper Airway Stimulation’s Impact on Sleep Apnea Comorbidities
The Inspire implant has been shown to improve sleepiness and functional outcomes. Now researchers...
All
LatestSorry, No Posts Found
Inspire Medical Files Registration Statement for Proposed IPO
Inspire Medical Systems Inc has filed a registration statement on Form S-1 with the US Securities...
Read MoreLivaNova PLC Acquires ImThera for $225 Million
ImThera Medical Inc, a privately owned company focused on neurostimulation for the treatment of obstructive sleep apnea (OSA), has been purchased by medical technology company LivaNova PLC as part of a transaction valued at...
Read More
As Sleep Surgery Evolves, Sleep Specialists Match Patients Who Fail CPAP to Personalized Treatments
Obstructive sleep apnea is a heterogeneous disease in which patients differ in their severity, physical features, and treatment preferences. For almost two decades, otolaryngologist and sleep medicine specialist Ofer Jacobowitz, MD, PhD, FAASM, of ENT and Allergy Associates LLP in New York City, has been matching CPAP, custom oral appliances, sleep surgery, and combination treatments to his patients.
Read MoreLivaNova to Acquire ImThera Medical (Developer of a Neurostimulation Sleep Apnea Therapy Device)
London-based LivaNova PLC has entered into an agreement to acquire the remaining outstanding interests in ImThera Medical, Inc. Headquartered in San Diego, Calif, ImThera is a privately held company focused on neurostimulation...
Read More
FDA Approves Implanted Device to Treat Central Sleep Apnea
The U.S. Food and Drug Administration on Friday approved a new treatment option for patients who...
Read More
Inspire Medical Systems’ Inspire Therapy Demonstrates Long-term Safety, Sustained Benefit Following 5 Years of Treatment
Inspire Medical Systems Inc, the manufacturer of the only FDA-approved active implantable device...
Read MoreInspire Medical Systems Completes 1,000th Implant
Inspire Medical Systems, Inc has reached a milestone with the 1,000th implant of Inspire therapy since FDA approval in April, 2014. As the only FDA-approved implantable device for obstructive sleep apnea patients who don’t get...
Read More
Implanted Device Successfully Treats Central Sleep Apnea
Results from an international randomized study show that an implanted nerve stimulator...
Read More
Inspire Medical Implant for OSA As Successful in General Clinical Population as in Clinical Trial
Results from a Penn case study of Inspire Medical Systems Inc hypoglossal nerve stimulation...
Read MoreDevelopers of Small Neurostimulator for Obstructive Sleep Apnea Raise $20 Million
Nyxoah SA, a medical device company focused on developing a neurostimulation-based ultra-small implant for patients suffering from obstructive sleep apnea (OSA), has raised €18 million ($20 million) in fresh capital. The...
Read More
SLEEP 2016 Presentations Show Significant, Sustained Benefits of Inspire Therapy for Sleep Apnea
Over the course of the the SLEEP 2016 meeting, Inspire Medical Systems Inc implantable therapy was...
Read More
At 3 Years, Inspire Upper Airway Stimulation Therapy Shows Significant Sustained Reductions in Sleep Apnea Severity
Inspire Medical Systems Inc this month announced the results of a landmark long-term clinical...
Read More
On the Beat
Shahrokh Javaheri, MD, sleep physician, TriHealth Sleep, is charting a new course in cardiovascular sleep medicine.
Read More
Microsemi’s RF Module Speeds Time-to-Market for Implantable Medical Device Designers
Microsemi Corporation announced the availability of the smallest radio module it has ever...
Read MoreInspire Therapy 18-Month Durability Research Shows Sustained Reductions in Obstructive Sleep Apnea Severity
The manuscript “Upper Airway Stimulation for Obstructive Sleep Apnea: Durability of the Treatment Effect at 18 months,” which discusses Inspire Upper Airway Stimulation (UAS) therapy, has been accepted for publication in SLEEP....
Read More